BioCardia Inc (BCDA) reports significant expense reductions and positive clinical trial results, despite financial constraints and market challenges..
Sports
BioCardia Inc (BCDA) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and Promising ...
BioCardia Inc (BCDA) reports significant expense reductions and positive clinical trial results, despite financial constraints and market challenges.